Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Progressive renal function decline begins in one third of patients with microalbuminuria and type 1 diabetes. This study examined whether this decline is associated with elevated excretion of inflammatory markers in urine. Five inflammatory markers (IL-6, IL-8, monocyte chemoattractant protein-1, interferon-gamma-inducible protein (IP-10), and macrophage inflammatory protein-1delta) were measured in urine samples from the First Joslin Study of the Natural History of Microalbuminuria in Type 1 Diabetes, a cohort recruited in 1991. Samples were obtained from 43 participants with microalbuminuria and stable renal function (nondecliners), from 28 with microalbuminuria and early progressive renal function decline (decliners), and from 74 with normoalbuminuria and stable renal function (reference). Urinary concentrations of all five inflammatory markers were significantly higher in decliners than in nondecliners, who were similar to the reference group. Multivariate analysis revealed that those with more than two markers elevated were more than five times as likely to have early progressive decline of renal function. In contrast, serum concentrations of C-reactive protein, IL-8, and macrophage inflammatory protein-1delta did not differ between decliners and nondecliners. These results support the hypothesis that inflammatory processes in the kidney contribute to the progression of nephropathy in patients with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Renal damage related to T2DM includes both structural (glomerular basement membrane thickening, mesangial expansion, interstitial fibrosis, loss of capillary architecture, hyalinosis of small and medium caliber arteries) and functional (dysfunction of the mitochondrial respiratory chain, over expression of proinflammatory cytokines such as interleukin (IL)-6, IL-8, IL-18, TNF-α, interferon (INF)-γ”
From GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art (2022) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Structural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
Thomson, A. W. (1994) · Cited by 1,116
Multiplexed particle-based flow cytometric assays
Vignali, D. A. A. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00238-6 · Cited by 913
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Self-citationMacrophage inflammatory protein-1
Maurer, M., & von Stebut, E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.019 · Cited by 767
Gilbert, R. E., & Cooper, M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00721.x · Cited by 649
Brenner and Rector's the Kidney
Brenner, B. M. (2003) · Medical Entomology and Zoology · Cited by 561
SEGERER, S., NELSON, P. J., & SCHLO[Combining Diaeresis]NDORFF, D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v111152 · Cited by 502
Krolewski, A. S., Laffel, L. M. B., Krolewski, M., Quinn, M., & Warram, J. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321902 · Cited by 452
Self-citationChow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., Rollin, B. J., & Tesch, G. H. (2006) · Kidney International · doi:10.1038/sj.ki.5000014 · Cited by 440
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., et al. (2006) · Diabetes · doi:10.2337/db06-0477 · Cited by 419
NF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080872 · Cited by 370
Self-citationWada, T., Furuichi, K., Sakai, N., Iwata, Y., Yoshimoto, K., Shimizu, M., Takeda, S.-I., Takasawa, K., Yoshimura, M., Kida, H., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00311.x · Cited by 341
Perkins, B. A., Nelson, R. G., Ostrander, B. E. P., Blouch, K. L., Krolewski, A. S., Myers, B. D., & Warram, J. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100854 · Cited by 323
Self-citationTang, S., Leung, J. C. K., Abe, K., Chan, K. W., Chan, L. Y. Y., Chan, T. M., & Lai, K. N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16079 · Cited by 296
The Pathogenesis of Chronic Renal Failure in Diabetic Nephropathy
Bohle, A., Wehrmann, M., Bogenschütz, O., Batz, C., Müller, G. A., & Müller, G. A. (1991) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80780-6 · Cited by 285
Chemokines and chemokine receptors are involved in the resolution or progression of renal disease
Anders, H.-J., Vielhauer, V., & Schlöndorff, D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00750.x · Cited by 270
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy
Banba, N., Nakamura, T., Matsumura, M., Kuroda, H., Hattori, Y., & Kasai, K. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00214.x · Cited by 267
Chow, F. Y., Nikolic-Paterson, D. J., Ma, F. Y., Ozols, E., Rollins, B. J., & Tesch, G. H. (2007) · Diabetologia · doi:10.1007/s00125-006-0497-8 · Cited by 250
Navarro, J. F., Milena, F. J., Mora, C., León, C., & García, J. (2006) · American Journal of Nephrology · doi:10.1159/000098004 · Cited by 220
The role of TNF-α in diabetic nephropathy: Pathogenic and therapeutic implications
NAVARRO, J., & MORAFERNANDEZ, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.011 · Cited by 198
Role of immunocompetent cells in nonimmune renal diseases
Rodríguez-Iturbe, B., Pons, H., Herrera-Acosta, J., & Johnson, R. J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051626.x · Cited by 187
In Situ Hybridization of Interleukin 6 in Diabetic Nephropathy
Suzuki, D., Miyazaki, M., Naka, R., Koji, T., Yagame, M., Jinde, K., Endoh, M., Nomoto, Y., & Sakai, H. (1995) · Diabetes · doi:10.2337/diab.44.10.1233 · Cited by 175
WHITE, K. E., & BILOUS, R. W. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191667 · Cited by 165
Vielhauer, V., Berning, E., Eis, V., Kretzler, M., Segerer, S., Strutz, F., Horuk, R., Gröne, H.-J., Schlöndorff, D., & Anders, H.-J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66038.x · Cited by 161
Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study
Krolewski, M., Eggers, P. W., & Warram, J. H. (1996) · Kidney International · doi:10.1038/ki.1996.527 · Cited by 160
Self-citationActivation of Tubular Epithelial Cells in Diabetic Nephropathy
Morcos, M., Sayed, A. A. R., Bierhaus, A., Yard, B., Waldherr, R., Merz, W., Kloeting, I., Schleicher, E., Mentz, S., Abd el Baki, R. F., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3532 · Cited by 157
Tashiro, K., Koyanagi, I., Saitoh, A., Shimizu, A., Shike, T., Ishiguro, C., Koizumi, M., Funabiki, K., Horikoshi, S., Shirato, I., et al. (2002) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.2057 · Cited by 141
Scott, L. J., Warram, J. H., Hanna, L. S., Laffel, L. M. B., Ryan, L., & Krolewski, A. S. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2842 · Cited by 136
Self-citationNavarro, J. F., Mora, C., Muros, M., & Garcia, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl469 · Cited by 122
Usefulness of a Highly Sensitive Urinary and Serum IL-6 Assay in Patients with Diabetic Nephropathy
Shikano, M., Sobajima, H., Yoshikawa, H., Toba, T., Kushimoto, H., Katsumata, H., Tomita, M., & Kawashima, S. (2000) · Nephron · doi:10.1159/000045634 · Cited by 121
Panzer, U., Steinmetz, O. M., Reinking, R. R., Meyer, T. N., Fehr, S., Schneider, A., Zahner, G., Wolf, G., Helmchen, U., Schaerli, P., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040364 · Cited by 98
Vilček, J. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50005-3 · Cited by 62
MacIsaac, R. J., Tsalamandris, C., Thomas, M. C., Premaratne, E., Panagiotopoulos, S., Smith, T. J., Poon, A., Jenkins, M. A., Ratnaike, S. I., Power, D. A., et al. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02112.x · Cited by 56
Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN)
NATORI, Y., Sekiguchi, M., Ou, Z., & Natori, Y. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4271321.x · Cited by 55
Glomerular Filtration Rate and Albuminuria: Twin Manifestations of Nephropathy in Diabetes
de Boer, I. H., & Steffes, M. W. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020189 · Cited by 44
Detection of Urinary MCP-1 in Patients withDiabetic Nephropathy
Saitoh, A., Sekizuka, K., Hayashi, T., Kaneko, S., Suzuki, Y., & Tomino, Y. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000045142 · Cited by 16
Urinary cytokines: clinically useful markers of chronic renal disease progression?
Wong, W., & Singh, A. K. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200111000-00012 · Cited by 11
[Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski, G., Pączek, L., Kropiewnicka, E., & Bartłomiejczyk, I. (2002) · PubMed · Cited by 6
Cited by
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
Jayne, D. R. W., Bruchfeld, A. N., Harper, L., Schaier, M., Venning, M. C., Hamilton, P., Burst, V., Grundmann, F., Jadoul, M., Szombati, I., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111179 · Cited by 607
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.048 · Cited by 378
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Rayego-Mateos, S., Morgado-Pascual, J. L., Opazo-Ríos, L., Guerrero-Hue, M., García-Caballero, C., Vázquez-Carballo, C., Mas, S., Sanz, A. B., Herencia, C., Mezzano, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113798 · Cited by 334
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Stenvinkel, P., Chertow, G. M., Devarajan, P., Levin, A., Andreoli, S. P., Bangalore, S., & Warady, B. A. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.04.023 · Cited by 297
Tuttle, K. R., Brosius, F. C., Adler, S. G., Kretzler, M., Mehta, R. L., Tumlin, J. A., Tanaka, Y., Haneda, M., Liu, J., Silk, M. E., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx377 · Cited by 284
“Although most of these are systemic cytokines, CCL2 (MCP-1) and CXCL10 (IP-10) were measured in urine, and urinary biomarkers appear to more closely track with inflammation in the kidney than systemic inflammation [44].”
Background
Metadata
- Authors
- Wolkow, P. P., Niewczas, M. A., Perkins, B., Ficociello, L. H., Lipinski, B., Warram, J. H., & Krolewski, A. S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2008-04
- Volume
- 19
- Issue
- 4
- Pages
- 789-797
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC2390964
- OpenAlex
- W1978728606
- Cited by
- 155
- References
- 41
- Citations by year
- 2025: 10 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 7 · 2017: 11 · 2016: 8 · 2015: 9 · 2014: 10 · 2013: 8 · 2012: 13
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK067638, R01-DK-41526, R01-DK67638, R01DK041526)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- type 1 diabetes, microalbuminuria, diabetic nephropathy, renal function decline, interleukin-6, interleukin-8, MCP-1, CXCL10, C-reactive protein, renal inflammation
- MeSH terms
- Adult, Albuminuria, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Humans, Inflammation, Male, Pilot Projects, Biomarkers, Cytokines, Disease Progression, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.